Alisa Lask - 14 May 2024 Form 4 Insider Report for NEPHROS INC (NEPH)

Role
Director
Signature
/s/ Christopher Melsha as attorney-in-fact for Alisa Lask pursuant to power of attorney previously filed.
Issuer symbol
NEPH
Transactions as of
14 May 2024
Transactions value $
$0
Form type
4
Filing time
16 May 2024, 16:26:53
Previous filing
15 Dec 2023
Next filing
03 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NEPH Common Stock 48.6K 14 May 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEPH Stock Option (right to buy) Award $0 +7.32K $0.00 7.32K 14 May 2024 Common Stock 7.32K $2.14 Direct F3
holding NEPH Stock Option (right to buy) 9.62K 14 May 2024 Common Stock 9.62K $5.22 Direct F1
holding NEPH Stock Option (right to buy) 5.57K 14 May 2024 Common Stock 5.57K $8.57 Direct F1
holding NEPH Stock Option (right to buy) 6.85K 14 May 2024 Common Stock 6.85K $8.06 Direct F1
holding NEPH Stock Option (right to buy) 7.06K 14 May 2024 Common Stock 7.06K $6.82 Direct F1
holding NEPH Stock Option (right to buy) 7.08K 14 May 2024 Common Stock 7.08K $1.07 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully exercisable.
F2 This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25.
F3 Represents options granted to the reporting person for her service on the Company's Board of Directors for 2023. This option vests as to 2,441 shares on each of 5/14/24, 5/14/25 and 5/14/26.